Lixisenatide
Products in Health Canada’s databases that list Lixisenatide as a medicinal or active ingredient. Its salts and forms that the databases name on their own have their own pages.
- Drug products
- 4
- 1 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 10
- Products in all
- 4
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| SOLIQUA (33 MCG) | 02478293 | Marketed | Sanofi-Aventis Canada Inc. | |
| ADLYXINE (10 MCG) | 02464276 | Cancelled Post Market | Sanofi-Aventis Canada Inc. | |
| ADLYXINE (20 MCG) | 02464284 | Cancelled Post Market | Sanofi-Aventis Canada Inc. | |
| ADLYXINE (0.05 MG) | 02464349 | Cancelled Post Market | Sanofi-Aventis Canada Inc. |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- SOLIQUADecember 11, 2025 · NOC 36521
- SOLIQUAOctober 11, 2025 · NOC 36167
- ADLYXINEJuly 11, 2023 · NOC 31208
- SOLIQUAJune 28, 2023 · NOC 31073
- SOLIQUAMay 3, 2021 · NOC 25771
- ADLYXINENovember 17, 2020 · NOC 24629
- SOLIQUANovember 16, 2020 · NOC 24609
- SOLIQUASeptember 17, 2020 · NOC 24235
- SOLIQUAJuly 6, 2018 · NOC 21058
- ADLYXINEMay 25, 2017 · NOC 19339